Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Polyphor AG
  6. News
  7. Sector news
    POLN   CH0106213793

POLYPHOR AG

(POLN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Sector news Biopharmaceuticals
04:43aSouth Korean Stocks Rise as Investors Move Past Omicron Fears; LG Chem Adds 6%
MT
12/06Goldman Sachs Starts Biogen at Neutral With $271 Price Target
MT
12/03Drugmakers cut prices by 62% on average to get China state insurance listing
RE
12/02Australia's CSL in exclusive talks for $7 billion buyout of Swiss Vifor Pharma - report
RE
12/02Vifor Says Regularly in Talks with Other Market Participants After Reports
CI
12/02CSL in Talks to Buy Vifor Pharma
CI
12/01Sage Therapeutics, Biogen Report Positive Data From Antidepressant Drug Candidate Zuran..
MT
12/01Viatris Wins Court Tussle Against Biogen as US Appeals Court Upholds Earlier Patent Rul..
MT
12/01Sage Therapeutics and Biogen Announce Positive, One-Year Zuranolone 50 mg Data in the O..
CI
11/30Biogen Loses Appeals Court Bid to Revive Multiple Sclerosis Drug Patent
MT
11/30US Court of Appeals Affirms District Court Decision That Biogen's 2028 Tecfidera Patent..
MT
11/30CANbridge Pharmaceuticals Secures WuXi Biologics Backing for $88 Million Hong Kong IPO
MT
11/29Australia shares rebound, gain 1% as investors absorb Omicron shock
RE
11/29Samsung Biologics, GreenLight Biosciences Enter Deal to Produce COVID-19 mRNA Vaccines
MT
11/29South Korean Stocks Fall for Fifth Session Over COVID-19 Variant Omicron Fears; Hyundai..
MT
11/24GreenLight Biosciences and Samsung Biologics Announce Collaboration to Build Capacity f..
CI
11/23Seqirus Announces U.S. FDA Approval for Multi-Dose Vial Presentation of First-Ever Adju..
CI
11/23South Korea’s Indexes Decline on Profit-Taking; Naver, LG Chem Decline over 2%
MT
11/22WuXi Biologics Announces Completion of GMP Production At 24,000L Line of Its Drug Subst..
CI
11/22Biogen's Alzheimer's Drug Reportedly Caused Brain Swelling in Over One-Third of Patient..
MT
11/22Study Shows Biogen's Alzheimer's Drug Reportedly Shows Brain Swelling in 35% of Patient..
MT
11/19RBC Cuts Price Target on Biogen to $277 From $295 Amid Alzheimer's Updates, Maintains S..
MT
11/19South Korean Stocks Break Three-Day Losses to Close Higher; Samsung Biologics Jumps 6% ..
MT
11/18Australia shares edge up on financials, healthcare boost
RE
11/18BMO Capital Initiates Coverage of Biogen With Outperform Rating, $315 Price Target
MT
11/18Asian Stock Markets Wobble on Tech, Property Outlooks
MT
11/18Nikkei 225 Off 0.3% Despite News on Government Stimulus Package
MT
11/18Novartis Said Considering Takeover in Biotech Sector
MT
11/18Nikkei dips but pares losses after report on larger stimulus
RE
11/17European Medicines Agency Committee Gives Negative Trend Vote on Biogen's Alzheimer's D..
MT
11/17Japanese shares dip as inflation worries hit global stocks
RE
11/17Health Care Stocks Flat To Lower Premarket Wednesday
MT
11/17Biogen, Eisai's Alzheimer's Drug Candidate Receives Negative Trend Vote by European Reg..
MT
11/17Biogen's Alzheimer's Drug Gets Negative Trend Vote in EU
DJ
11/17Biogen Inc. and Eisai Co., Ltd. Announces an Update on the Ongoing Review of the Market..
CI
11/16Biogen Secures European Marketing Approval for Multiple Sclerosis Treatment
MT
11/16Biogen Gets Europe OK for Vumerity Multiple Sclerosis Drug
DJ
11/16The European Commission Grants Marketing Authorization for VUMERITY? (diroximel fumarat..
CI
11/15Biogen's research chief Alfred Sandrock to retire
RE
11/15Biogen Inc. Announces Executive Changes
CI
11/15Samsung Biologics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
11/15Samsung's Lee visits U.S ahead of likely $17 billion chip plant decision-media
RE
11/15S.Korea stocks end 1% higher on chip, biopharma boost, U.S. data in focus
RE
11/15Australia shares end higher on strong Chinese data
RE
11/12REFILE-UPDATE 4-Biden will nominate industry-friendly Califf to lead U.S. FDA
RE
11/12Health Care Stocks Gain Premarket Friday
MT
11/11Biogen, Eisai Alzheimer Treatment Shows Positive Signs in Advanced Trial
DJ
11/11Biogen Says Clinical Trial Data Show Aduhelm Reduced Levels of Protein Linked With Alzh..
MT
11/11Biogen says Aduhelm lowers levels of second protein associated with Alzheimer's
RE
11/11Biogen Inc. and Eisai Co., Ltd. Announce New Phase 3 Data Show Positive Correlation Bet..
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on POLYPHOR AG